United States

People: RiceBran Technologies (RIBT.OQ)

RIBT.OQ on NASDAQ Stock Exchange Capital Market

20 Aug 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Smith, Robert 

Dr. Robert Smith, Ph.D. is no longer Chief Executive Officer, President and Director of the Company effective as of September 30, 2018. He has served as our director and as our chief executive officer and president since December 2016, interim chief executive officer from August 2016 to December 2016, our chief operating officer from July 2016 to August 2016, our senior vice president of operations and R&D from November 2014 to June 2016, our senior vice president of sales and business development November 2013 to November 2014, and senior vice president of business development from March 2012 to November 2013. Dr. Smith brings over 20 years of experience managing research and development and business development in the Ag-biotech industry. He served as director of business development at HerbalScience Group from 2007 to 2010 and worked at Affynis LLC from 2010 to 2012 as a consultant. Dr. Smith has also served as director of research and developments at Global Protein Products Inc. and PhycoGen Inc., and was project leader at Dekalb Genetics, a Monsanto Company. Dr. Smith was a research assistant professor at the Ag-Biotech Center at Rutgers University and did his post-doctoral work in plant molecular biology at the University of Missouri-Columbia. He holds a Doctor of Philosophy degree in molecular genetics and cell biology from the University of Chicago and a bachelor of arts degree in biology from the University of Chicago.

Basic Compensation

Total Annual Compensation, USD 216,346
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 6,120
Fiscal Year Total, USD 222,466

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --